A-262 Targeting the hyperactive STAT3/5 Pathway in Cutaneous T-Cell Lymphoma: superior efficacy of multi-kinase inhibitor IQDMA over conventional PUVA therapy.

Autor: Dey, S. (AUTHOR), Sorger, H. (AUTHOR), Schlederer, M. (AUTHOR), Perchthaler, I. (AUTHOR), Kenner, L. (AUTHOR), Moriggl, R. (AUTHOR), Wolf, P. (AUTHOR)
Zdroj: European Journal of Cancer. 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: